Cargando…

Microdose Lithium Protects against Pancreatic Islet Destruction and Renal Impairment in Streptozotocin-Elicited Diabetes

Psychiatric use of lithium has been associated with hypoglycemic effects, but its effect on type 1 diabetes mellitus (T1D) is unknown. In streptozotocin (STZ) induced murine models of T1D, microdose lithium therapy improved hyperglycemia, attenuated body weight loss and prevented early signs of diab...

Descripción completa

Detalles Bibliográficos
Autores principales:	Zhang, Jiahui, Anshul, Fnu, Malhotra, Deepak K., Jaume, Juan, Dworkin, Lance D., Gong, Rujun
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	MDPI 2021
Materias:	Article
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7835906/ https://www.ncbi.nlm.nih.gov/pubmed/33478120 http://dx.doi.org/10.3390/antiox10010138

Ejemplares similares

Therapeutic Targeting of SGLT2: A New Era in the Treatment of Diabetes and Diabetic Kidney Disease
por: Shaffner, James, et al.
Publicado: (2021)

Rationale and Design of Assessing the Effectiveness of Short-Term Low-Dose Lithium Therapy in Averting Cardiac Surgery-Associated Acute Kidney Injury: A Randomized, Double Blinded, Placebo Controlled Pilot Trial
por: Sharif, Sairah, et al.
Publicado: (2021)

Microdose lithium reduces cellular senescence in human astrocytes - a potential pharmacotherapy for COVID-19?
por: Viel, Tania, et al.
Publicado: (2020)

Self-Rated Effectiveness of Microdosing With Psychedelics for Mental and Physical Health Problems Among Microdosers
por: Hutten, Nadia R. P. W., et al.
Publicado: (2019)

Microdosing: Concept, Application and Relevance
por: Tewari, Tushar, et al.
Publicado: (2010)

Asking questions of psychedelic microdosing
por: Cameron, Lindsay P
Publicado: (2021)

Pharmacological Melanocortin 5 Receptor Activation Attenuates Glomerular Injury and Proteinuria in Rats With Puromycin Aminonucleoside Nephrosis
por: Chen, Bohan, et al.
Publicado: (2022)

Age-related GSK3β overexpression drives podocyte senescence and glomerular aging
por: Fang, Yudong, et al.
Publicado: (2022)

On the rate of destruction of lithium in the sun
por: Christensen-Dalsgaard, J, et al.
Publicado: (1991)

CD103 Expression Is Required for Destruction of Pancreatic Islet Allografts by CD8(+) T Cells
por: Feng, Ye, et al.
Publicado: (2002)

A systematic study of microdosing psychedelics
por: Polito, Vince, et al.
Publicado: (2019)

The therapeutic potential of microdosing psychedelics in depression
por: Kuypers, Kim P.C.
Publicado: (2020)

GSK3β-mediated Keap1-independent regulation of Nrf2 antioxidant response: A molecular rheostat of acute kidney injury to chronic kidney disease transition
por: Lu, Minglei, et al.
Publicado: (2019)

Zebularine Induces Long-Term Survival of Pancreatic Islet Allotransplants in Streptozotocin Treated Diabetic Rats
por: Nittby, Henrietta, et al.
Publicado: (2013)

Melanocortin System in Kidney Homeostasis and Disease: Novel Therapeutic Opportunities
por: Chang, Mingyang, et al.
Publicado: (2021)

Chronic Microdose Lithium Treatment Prevented Memory Loss and Neurohistopathological Changes in a Transgenic Mouse Model of Alzheimer's Disease
por: Nunes, Marielza Andrade, et al.
Publicado: (2015)

BACE1 inhibition by microdose lithium formulation NP03 rescues memory loss and early stage amyloid neuropathology
por: Wilson, E N, et al.
Publicado: (2017)

Adults who microdose psychedelics report health related motivations and lower levels of anxiety and depression compared to non-microdosers
por: Rootman, Joseph M., et al.
Publicado: (2021)

Psilocybin microdosers demonstrate greater observed improvements in mood and mental health at one month relative to non-microdosing controls
por: Rootman, Joseph M., et al.
Publicado: (2022)

Mineralocorticoid receptor: A hidden culprit for hemodialysis vascular access dysfunction
por: Chen, Bohan, et al.
Publicado: (2018)

Phase 0 - Microdosing strategy in clinical trials
por: Rani, P. Usha, et al.
Publicado: (2008)

Psychedelic microdosing benefits and challenges: an empirical codebook
por: Anderson, Thomas, et al.
Publicado: (2019)

The ageing kidney: Molecular mechanisms and clinical implications
por: Fang, Yudong, et al.
Publicado: (2020)

Correction: Chronic Microdose Lithium Treatment Prevented Memory Loss and Neurohistopathological Changes in a Transgenic Mouse Model of Alzheimer's Disease
por: Nunes, Marielza Andrade, et al.
Publicado: (2015)

Inhibition of glycogen synthase kinase 3β prevents NSAID-induced acute kidney injury
por: Bao, Hao, et al.
Publicado: (2012)

The Role of Interleukin-1β in Destruction of Transplanted Islets
por: Chen, Cheng, et al.
Publicado: (2020)

Author Correction: Psilocybin microdosers demonstrate greater observed improvements in mood and mental health at one month relative to non-microdosing controls
por: Rootman, Joseph M., et al.
Publicado: (2022)

Effects of a novel curcumin derivative on insulin synthesis and secretion in streptozotocin-treated rat pancreatic islets in vitro
por: Aziz, Mohammed Talaat Abdel, et al.
Publicado: (2014)

Morphological Change in Pancreatic Islets, Insulin Binding and Intracellular Glucose Metabolism in Adipocytes of Streptozotocin-induced Diabetic Rats(*)
por: Cha, Bong Yun, et al.
Publicado: (1987)

The specificity of rejection and the absence of susceptibility of pancreatic islet beta cells to nonspecific immune destruction in mixed strain islets grafted beneath the renal capsule in the rat
Publicado: (1989)

Memory-like Liver Natural Killer Cells are Responsible for Islet Destruction in Secondary Islet Transplantation
por: Saeki, Y., et al.
Publicado: (2019)

Motives and Side-Effects of Microdosing With Psychedelics Among Users
por: Hutten, Nadia R P W, et al.
Publicado: (2019)

Self-blinding citizen science to explore psychedelic microdosing
por: Szigeti, Balázs, et al.
Publicado: (2021)

Buprenorphine Microdosing Cross Tapers: A Time for Change
por: Raheemullah, Amer, et al.
Publicado: (2022)

Activation of mineralocorticoid receptor by ecdysone, an adaptogenic and anabolic ecdysteroid, promotes glomerular injury and proteinuria involving overactive GSK3β pathway signaling
por: Lu, Minglei, et al.
Publicado: (2018)

Soluble FAS ligand is not required for pancreatic islet inflammation or beta-cell destruction in non-obese diabetic mice
por: Trivedi, Prerak M., et al.
Publicado: (2019)

Orexin-1 Receptor Co-Localizes with Pancreatic Hormones in Islet Cells and Modulates the Outcome of Streptozotocin-Induced Diabetes Mellitus
por: Adeghate, Ernest, et al.
Publicado: (2010)

Co-Transplantation of Endothelial Progenitor Cells and Pancreatic Islets to Induce Long-Lasting Normoglycemia in Streptozotocin-Treated Diabetic Rats
por: Quaranta, Paola, et al.
Publicado: (2014)

Protective Effects of the Mushroom Lactarius deterrimus Extract on Systemic Oxidative Stress and Pancreatic Islets in Streptozotocin-Induced Diabetic Rats
por: Mihailović, Mirjana, et al.
Publicado: (2015)

Global gene expression profiling of pancreatic islets in mice during streptozotocin-induced β-cell damage and pancreatic Glp-1 gene therapy
por: Tonne, Jason M., et al.
Publicado: (2013)

Cannot write session to /tmp/vufind_sessions/sess_5ln9pjah94phu92pe7b7ci24k2